PEPG EVP Paul Streck buys 8,375 shares at $1.24 amid 92.2% decline from 52-week high; company posted $-30.2M net loss.
Paul Streck, EVP and Head of R&D, purchased 8,375 shares at $1.24, increasing his holdings by 43.1%. The transaction occurred as the stock trades at $1.44, down 92.2% from its 52-week high of $18.55 and fallen 36.8% over the past 90 days. PepGen reported a full-year net loss of $-30.2M, indicating material operational challenges. The combination of a junior insider (R&D leader) accumulating shares in a depressed price environment while the company remains unprofitable warrants investor attention to execution and capital allocation risk.